Major Depressive Disorder

Showing NaN - NaN of 155

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD Trial in New York (Siemens 7T MRI, Sham Neurofeedback)

Recruiting
  • Major Depressive Disorder
  • Siemens 7T MRI
  • Sham Neurofeedback
  • New York, New York
    Icahn School Of Medicine at Mount Sinai
Jul 5, 2023

Depression, Suicidal Ideation, MDD Trial in New York ("Engage & Connect" Psychotherapy, Symptom Review and Psychoeducation

Not yet recruiting
  • Depression
  • +3 more
  • "Engage & Connect" Psychotherapy
  • Symptom Review and Psychoeducation (SRP)
  • New York, New York
    Weill Cornell Medicine
Jun 28, 2023

MDD, Apathy Trial in New York, White Plains (Targeted Cognitive Training Intervention, General Cognitive Training Intervention)

Not yet recruiting
  • Major Depressive Disorder
  • Apathy
  • Targeted Cognitive Training Intervention
  • General Cognitive Training Intervention
  • New York, New York
  • +1 more
May 17, 2023

MDD Trial in United States (Lumateperone, Placebo)

Recruiting
  • Major Depressive Disorder
  • Pico Rivera, California
  • +17 more
May 9, 2023

MDD, Treatment Resistant Depression Trial in New York (Medtronic Percept PC DBS system)

Recruiting
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • Medtronic Percept PC DBS system
  • New York, New York
    Icahn School of Medicine at Mount Sinai, Mount Sinai West
Mar 6, 2023

MDD Trial in New York (Empagliflozin)

Not yet recruiting
  • Major Depressive Disorder
  • New York, New York
    NYU Langone Health
Feb 24, 2023

MDD Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • Saraland, Alabama
  • +46 more
Jan 18, 2023

MDD Trial in United States (REL-1017)

Recruiting
  • Major Depressive Disorder
  • Saraland, Alabama
  • +102 more
Jan 18, 2023

Alzheimer, MDD Trial in New York, Orangeburg (Escitalopram Oxalate, Placebo)

Recruiting
  • Alzheimer Disease
  • Major Depressive Disorder
  • Escitalopram Oxalate
  • Placebo
  • New York, New York
  • +1 more
Dec 29, 2022

MDD Trial in Boston, New York (Transcranial Photobiomodulator, Sham)

Not yet recruiting
  • Major Depressive Disorder
  • Transcranial Photobiomodulator
  • Sham
  • Boston, Massachusetts
  • +3 more
Dec 7, 2022

MDD Trial in New York (SEP-363856, Placebo)

Recruiting
  • Major Depressive Disorder
  • New York, New York
    For additional information regarding sites, contact 844-687-8522
Nov 14, 2022

MDD Trial in New York, Houston (XEN1101, Placebo)

Recruiting
  • Major Depressive Disorder
  • New York, New York
  • +1 more
Nov 8, 2022

MDD Trial in New York (Fisher Wallace Cranial Electrotherapy Stimulator (Active Device), Fisher Wallace Cranial Electrotherapy

Completed
  • Major Depressive Disorder
  • Fisher Wallace Cranial Electrotherapy Stimulator (Active Device)
  • Fisher Wallace Cranial Electrotherapy Stimulator (Placebo Device)
  • New York, New York
    New York Neuromodulation Medical, PLLC
Nov 3, 2022

MDD, Insomnia Trial in United States (SAGE-217, Placebo)

Terminated
  • Major Depressive Disorder
  • Insomnia
  • Little Rock, Arkansas
  • +27 more
Oct 13, 2022

MDD, Generalized Anxiety Disorder Trial in New York (HPDT-DA-013)

Recruiting
  • Major Depressive Disorder
  • Generalized Anxiety Disorder
  • HPDT-DA-013
  • New York, New York
    Happify Health (Remote)
Aug 5, 2022

Suicidal Ideation, MDD Trial in New York (Belbuca Buccal Product, Placebo)

Recruiting
  • Suicidal Ideation
  • Major Depressive Disorder
  • Belbuca Buccal Product
  • Placebo
  • New York, New York
    New York State Psychiatric Institute
Jul 30, 2022

MDD Trial in United States (XEN1101 10 mg, XEN1101 20 mg, Placebo)

Recruiting
  • Major Depressive Disorder
  • XEN1101 10 mg
  • +2 more
  • Lafayette, California
  • +5 more
Jul 11, 2022

Treatment Resistant Depression, MDD Trial in New York (Repetitive Transcranial Magnetic Stimulation)

Recruiting
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Repetitive Transcranial Magnetic Stimulation
  • New York, New York
    Weill Cornell Medicine
Jun 24, 2022

MDD Trial in New York (Cognitive Behavior Therapy (CBT), Nonspecific Supportive Therapy (PBO))

Recruiting
  • Major Depressive Disorder
  • Cognitive Behavior Therapy (CBT)
  • Nonspecific Supportive Therapy (PBO)
  • New York, New York
    New York State Psychiatric Institute
Jun 22, 2022

MDD Trial in New York (Ketamine)

Completed
  • Major Depressive Disorder
  • New York, New York
    New York State Psychiatric Institute/Columbia University
May 31, 2022

MDD Trial in New York ("Engage & Connect" Psychotherapy, Symptom Review and Psychoeducation (SRP))

Recruiting
  • Major Depressive Disorder
  • "Engage & Connect" Psychotherapy
  • Symptom Review and Psychoeducation (SRP)
  • New York, New York
    Weill Cornell Medicine
May 23, 2022

MDD Trial in United States (SP-624, Placebo)

Active, not recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +38 more
May 13, 2022

Post Traumatic Stress Disorder, MDD Trial in New York (Escitalopram, Duloxetine)

Terminated
  • Post Traumatic Stress Disorder
  • Major Depressive Disorder
  • New York, New York
    New York State Psychiatric Institute
Apr 12, 2022

MDD Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +57 more
May 9, 2022

MDD Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +52 more
Apr 14, 2022